APPLIED THERAPEUTICS INC (APLT) Stock Earnings & Estimates
NASDAQ:APLT - US03828A1016 - Common Stock
0.5201 USD
+0.03 (+5.56%)
0.5305 USD
+0.01 (+2%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.993M | 455K -95.45% | 339.997K -25.28% | 20.506M 5,931.24% | 72.055M 251.38% | 120.21M 66.83% | 209.78M 74.51% | 327.99M 56.35% | 447.85M 36.54% | 574.73M 28.33% | ||
| EBITDA YoY % growth | -82.95M 25.51% | -64.182M 22.63% | -103.874M -61.84% | -75.072M 27.73% | -41.779M 44.35% | 1.183M 102.83% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -82.95M 21.46% | -64.535M 22.20% | -104.299M -61.62% | -98.676M 5.39% | -100.667M -2.02% | -79.42M 21.11% | -60.502M 23.82% | 7.975M 113.18% | 103.04M 1,192.04% | 208.14M 102.00% | 322.84M 55.11% | |
| Operating Margin | N/A | -645.80% | -22,922.86% | -29,022.67% | -490.92% | -110.22% | -50.33% | 3.80% | 31.42% | 46.48% | 56.17% | |
| EPS YoY % growth | -2.24 45.63% | -1.36 39.29% | -0.80 41.18% | -0.58 27.01% | -0.52 11.35% | -0.29 44.83% | -0.15 46.43% | 0.02 113.33% | 0.26 1,150.00% | 0.48 88.00% | 0.68 42.55% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.14 70.25% | -0.15 -144.05% | -0.16 -4.26% | -0.16 -6.54% | -0.13 11.91% | -0.14 4.09% | -0.10 34.78% | -0.09 42.55% | -0.06 51.35% | -0.03 78.05% |
| Revenue Q2Q % growth | 339.997K 178.69% | 11.914M 3,404.15% | 14.479M | 15.851M | 19.431M | 25.724M 115.91% | 32.191M 122.33% | |||
| EBITDA Q2Q % growth | -23.348M 20.58% | -23.552M 27.75% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -24.359M 18.10% | -24.728M 25.12% | -27.044M -5.95% | -27.469M -18.92% | -18.824M 22.72% | -24.245M 1.95% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.15 -850.00% | -0.16 | 0.01 | 6.92% |
| Q1 2025 Q2Q % growth | -0.15 77.61% | -0.19 | 0.04 | 22.60% |
| Q4 2024 Q2Q % growth | 0.33 197.06% | -0.18 | 0.51 | 282.27% |
| Q3 2024 Q2Q % growth | -0.48 -2.13% | -0.16 | -0.32 | -197.84% |
| Q2 2024 Q2Q % growth | 0.02 105.41% | -0.17 | 0.19 | 111.97% |
| Q1 2024 Q2Q % growth | -0.67 -272.22% | -0.16 | -0.51 | -311.83% |
| Q4 2023 Q2Q % growth | -0.34 -112.50% | -0.23 | -0.11 | -46.20% |
| Q3 2023 Q2Q % growth | -0.47 -17.50% | -0.26 | -0.21 | -77.68% |
| Q2 2023 Q2Q % growth | -0.37 53.75% | -0.27 | -0.10 | -36.88% |
| Q1 2023 Q2Q % growth | -0.18 79.55% | -0.31 | 0.13 | 42.42% |
| Q4 2022 Q2Q % growth | -0.16 84.62% | -0.47 | 0.31 | 66.07% |
| Q3 2022 Q2Q % growth | -0.40 63.30% | -0.49 | 0.09 | 17.89% |
| Q2 2022 Q2Q % growth | -0.80 19.19% | -0.80 | 0.00 | 0.06% |
| Q1 2022 Q2Q % growth | -0.88 12.00% | -0.85 | -0.03 | -3.50% |
| Q4 2021 Q2Q % growth | -1.04 1.89% | -1.27 | 0.23 | 18.25% |
| Q3 2021 Q2Q % growth | -1.09 18.05% | -1.19 | 0.10 | 8.16% |
| Q2 2021 Q2Q % growth | -0.99 22.05% | -1.15 | 0.16 | 14.12% |
| Q1 2021 Q2Q % growth | -1.00 -69.49% | -1.03 | 0.03 | 2.64% |
| Q4 2020 Q2Q % growth | -1.06 32.48% | -1.28 | 0.22 | 16.93% |
| Q3 2020 Q2Q % growth | -1.33 -111.11% | -1.04 | -0.29 | -28.23% |
| Q2 2020 Q2Q % growth | -1.27 -111.67% | -0.70 | -0.57 | -81.08% |
| Q1 2020 Q2Q % growth | -0.59 62.66% | -0.83 | 0.24 | 29.34% |
| Q4 2019 Q2Q % growth | -1.57 | -0.66 | -0.91 | -138.86% |
| Q3 2019 Q2Q % growth | -0.63 | -0.50 | -0.13 | -24.95% |
| Q2 2019 Q2Q % growth | -0.60 | -0.50 | -0.10 | -19.14% |
| Q1 2019 Q2Q % growth | -1.58 | -0.41 | -1.17 | -282.47% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -100.00% | 425.003K | -425.003K | -100.00% |
| Q1 2025 Q2Q % growth | -100.00% | 4.675M | -4.675M | -100.00% |
| Q4 2024 Q2Q % growth | 100.00% | 140.25K | -140.25K | -100.00% |
| Q2 2024 Q2Q % growth | 144K | 2.55M | -2.406M | -94.35% |
| Q1 2024 Q2Q % growth | 190K -98.22% | 3.4M | -3.21M | -94.41% |
| Q2 2023 Q2Q % growth | 8.16M | -8.16M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.45% | 20.76% | -0.09% | 14.55% |
| Revenue | 4.17% | -74.13% | -85.51% | -96% |